http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S55151584-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dfd617dc43a4c986d2dd81e4cb39d9dd
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
filingDate 1979-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5742f5321fbc613a9e91149331f6b7f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33f81cf3b74d1928e734a33e2ac50a73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_166c5bcc3053f8a20b55b1a164a1b50a
publicationDate 1980-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S55151584-A
titleOfInvention Preparation of 1,8-naphthyridine derivative
abstract PURPOSE: To obtain the title compound useful as an intermediate for an antibacterial agent in high yields, by condensing a -4-hydroxy-7-methyl-1,8-naphthyridine-3- carboxylic acid derivative with chloral, followed by alkylation and reaction with an organic acid. n CONSTITUTION: A compound shown by the formula I (R 3 and R 6 are lower alkyl) is condensed with chloral in a polor solvent, e.g., acetic acid, DMF, etc. or without the solvent under heating from room temperatures to reflux temperatures to give a compound shown by the formula II, which is reacted with an alkylating agent, e.g., a halogenated alkyl, a dialkylsulfuric acid, etc. in the presence of a deoxidizer, e.g., KOH, etc. in a polar solvent, e.g., DMF, under heating to give a compound shown by the formula III. The compound shown by the formula III is heated in the presence of an organic strong acid, e.g., tosyl acid, etc. in acetic acid, acetic anhydidride, or their mixture at 50W140°C to prepare a compound shown by the formula IV. n COPYRIGHT: (C)1980,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9975892-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8551990-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008046135-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9133188-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9573945-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8614212-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8293737-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8906912-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10954231-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9023848-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10233181-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017105818-A
priorityDate 1979-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394734
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487580
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236602149
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70581891
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6407
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350

Total number of triples: 31.